Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
per week
for 24 weeks
// //

Aptose Biosciences Inc TSX: APS-T

Today's Change
Real-Time Last Update TSX Last Sale

Today's Trading

Day Low 1.55
Day High 1.62
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. CG026806 (CG-806), its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL).


Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Stocks in play: Aptose Biosciences Inc. - Baystreet - Wed Dec 29, 2021
Baystreet - SYNDTGAM
Wed Dec 29, 2021
Will participate in two separate biotech events in January 2022: the H.C. Wainwright BIOCONNECT Virtual ...
Aptose to Participate in Two Biotech Events in January 2022
Globe Newswire - Wed Dec 29, 2021
Globe Newswire - PRTGAM
Wed Dec 29, 2021
— H.C. Wainwright BIOCONNECT Virtual Conference — — 11th Annual LifeSci Partners Corporate Access Event — SAN DIEGO and TORONTO, Dec. 29, 2021 ...
Aptose Provides Update on APTO-253 Program
Globe Newswire - Mon Dec 20, 2021
Globe Newswire - PRTGAM
Mon Dec 20, 2021
-- Clinical development of the MYC repressor APTO-253 will be discontinued -- -- Company will focus on advancing kinome inhibitor pipeline -- SAN DIEGO...
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.52 +4.61% increase
on 01/19/22
Period Open:1.80
Price movement based on the high, low and last over the given period.
1.99 -20.10% decrease
on 12/21/21
-0.21 (-11.67%) decrease
since 12/20/21
3-Month 1.39 +14.39% increase
on 12/14/21
Period Open:2.65
Price movement based on the high, low and last over the given period.
3.53 -54.96% decrease
on 11/17/21
-1.06 (-40.00%) decrease
since 10/20/21
52-Week 1.39 +14.39% increase
on 12/14/21
Period Open:5.48
Price movement based on the high, low and last over the given period.
9.00 -82.33% decrease
on 03/24/21
-3.89 (-70.99%) decrease
since 01/20/21

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2022.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2022 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies